UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: LidokainAgu-10mgml-InjSol-SE-AJ-RA

Generated Narrative: RegulatedAuthorization LidokainAgu-10mgml-InjSol-SE-AJ-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/56122

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100000357-00056122,http://ema.europa.eu/fhir/eurdId#10934; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Solution for injection in pre-filled syringe; indication = Lidokain Aguettant är avsett för infiltrationsanestesi och perifer nervblockad. Lidokain Aguettant 10 mg/ml är avsett för vuxna och barn över 2 år. Lidokain Aguettant 20 mg/ml är avsett för vuxna.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = lidocaine

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2018-08-03

holder: Organization Laboratoire Aguettant

Cases

-TypeDate[x]
*First Authorisation2018-08-03